Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials

BM Ellingson, ER Gerstner, Marion Smits, RY Huang, R Colen, LE Abrey, DT Aftab, GM Schwab, C Hessel, RJ Harris, A Chakhoyan, Renske Gahrmann, WB Pope, K Leu, C Raymond, DC Woodworth, John de Groot, PY Wen, TT Batchelor, Martin van den BentTF Cloughesy

Research output: Contribution to journalArticleAcademicpeer-review

56 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5745-5756
Number of pages12
JournalClinical Cancer Research
Issue number19
Publication statusPublished - 2017

Research programs

  • EMC NIHES-03-30-02

Cite this